Jochen Buck   Professor of Pharmacology

Publications

Sort by

selected publications

Research

Sort by

Funding awarded

  • Optimization of lead candidates for an on-demand male contraceptive  awarded by National Institute of Child Health & Human Development Principal Investigator 2023 - 2028
  • Comparative studies on the regulation of metabolism during sperm capacitation  awarded by National Institute of Child Health & Human Development Principal Investigator 2022 - 2027
  • ADCY10 inhibitors as pre-coital, ''on-demand'', non-hormonal male contraceptives  awarded by Male Contraceptive Initiative Co-Investigator 2022 - 2024
  • On-demand nonhormonal male contraception via ADCY10 inhibition  awarded by National Institute of Child Health & Human Development Co-Principal Investigator 2023 - 2026
  • Weill Cornell/Rockefeller/Sloan Kettering MST Program  awarded by National Institute of General Medical Sciences Key Personnel 2019 - 2024
  • Microbicide R&D to Advance HIV Prevention Technologies through Responsive Innovation and eXcellence, MATRIX  awarded by United States Agency for International Development Principal Investigator Subaward 2021 - 2025

Background

Contact

full name

  • Jochen Buck

primary email

  • jobuck@med.cornell.edu

External Relationships

externalRelationships

  • Relationships and collaborations with for-profit and not-for-profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

    Ownership refers to any financial stake an individual owns in any company (e.g., stock options, equity interest)Ownership:
    Sacyl Pharmaceuticals, Inc.